Loading...

WuXi Biologics (Cayman) Inc.

WXIBFPNK
HealthcareBiotechnology
$3.20
$0.20(6.67%)

WuXi Biologics (Cayman) Inc. (WXIBF) Company Profile & Overview

Explore WuXi Biologics (Cayman) Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

WuXi Biologics (Cayman) Inc. (WXIBF) Company Profile & Overview

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.

SectorHealthcare
IndustryBiotechnology
CEODr. Zhisheng Chen Ph.D.

Contact Information

No. 108, Meiliang Road, Wuxi, 214092

Company Facts

12,575 Employees
IPO DateJan 30, 2018
CountryCN
Actively Trading

Frequently Asked Questions